Literature DB >> 2844586

C-reactive protein decreases protein phosphorylation in stimulated human neutrophils.

R Buchta1, R Gennaro, M Pontet, M Fridkin, D Romeo.   

Abstract

Treatment of human neutrophils with C-reactive protein (CRP) causes a concentration-dependent in the extent of activation of superoxide production and of granule secretion, induced by phorbol-12-myristate-13-acetate (PMA) or N-formyl-L-methionyl-L-leucyl-L-phenylalanine (fMLF). The same treatment also causes a significant reduction in the degree of PMA- and fMLF-stimulated phosphorylation of several cell proteins. These include the proteins of 43-47 kDa, whose extent of phosphorylation correlates with the activation of superoxide production and of secretion. Contrary to the effects exerted on protein phosphorylation, CRP does not affect the fMLF-elicited increase in neutrophil cytosolic Ca2+.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2844586     DOI: 10.1016/0014-5793(88)80195-9

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  5 in total

1.  Metabolic and scintigraphic studies of radioiodinated human C-reactive protein in health and disease.

Authors:  D M Vigushin; M B Pepys; P N Hawkins
Journal:  J Clin Invest       Date:  1993-04       Impact factor: 14.808

2.  C-reactive protein (CRP) peptides inactivate enolase in human neutrophils leading to depletion of intracellular ATP and inhibition of superoxide generation.

Authors:  E G Shephard; R Anderson; O Rosen; M Fridkin
Journal:  Immunology       Date:  1992-05       Impact factor: 7.397

Review 3.  Evidence for C-reactive protein's role in (CRP) vascular disease: atherothrombosis, immuno-regulation and CRP.

Authors:  Sean P Mazer; LeRoy E Rabbani
Journal:  J Thromb Thrombolysis       Date:  2004-04       Impact factor: 2.300

4.  The regulation of superoxide generation and nitric oxide synthesis by C-reactive protein.

Authors:  S Ratnam; S Mookerjea
Journal:  Immunology       Date:  1998-08       Impact factor: 7.397

Review 5.  An overview on human serum lectins.

Authors:  S Beulaja Manikandan; R Manikandan; M Arumugam; P Mullainadhan
Journal:  Heliyon       Date:  2020-08-27
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.